至本医疗科技（上海）有限公司 OrigiMed

Founded 2016 China

China 142 employees Series B Health Care

OrigiMed is a China-based healthcare technology company founded in 2016. The company specializes in the development and clinical application of oncology molecular biology technologies. OrigiMed's main focus is to provide comprehensive and accurate molecular-level information to assist physicians in precision cancer treatment. The company has established six independent intellectual property platforms for genetic testing in Shanghai, a software copyright patented information processing supercomputing center, an international standard precision tumor research and development center, and a self-developed "Tracing to the Origin" product series. OrigiMed's business network covers five major regions in China and is committed to the integrated market cooperation model of precision diagnosis and treatment of cancer. The company's slogan "Tracing the Origin of Cancer, to the Foundation of Diagnosis and Treatment," reflects its dedication to precise oncology medical testing, setting industry standards, upholding ethical principles, and providing scientifically rigorous testing services. Although there is no information available on the last investment or investors, OrigiMed's innovative approach to cancer treatment and its comprehensive infrastructure showcase potential for growth and impact in the healthcare industry.

FAQ About 至本医疗科技（上海）有限公司 OrigiMed

至本医疗科技（上海）有限公司是一家科技转化型公司，专注于肿瘤分子生物学技术的研发及临床应用转化。致力于为每一位癌症患者提供全面准确的分子水平信息，辅助医生的精准治疗。至本医疗科技在上海创建 6 大自主知识产权平台的基因检测中心；拥有流程一体化等方面 6 项软件著作权专利的信息处理超算中心；国际标准的...

至本医疗科技（上海）有限公司 OrigiMed was founded in 2016.

至本医疗科技（上海）有限公司 OrigiMed is headquartered in China.

至本医疗科技（上海）有限公司 OrigiMed operates in Health Care.

至本医疗科技（上海）有限公司 OrigiMed has approximately 142 employees.

Top alternatives and competitors to 至本医疗科技（上海）有限公司 OrigiMed include ACT Genomics, Regional Cancer Care Associates, Notable, Geneseeq Technology Inc., Resilience Care. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.

至本医疗科技（上海）有限公司 OrigiMed and ACT Genomics are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

General Information

Discover More

About 至本医疗科技（上海）有限公司 OrigiMed

至本医疗科技（上海）有限公司 OrigiMed Alternatives & Competitors

FAQ About 至本医疗科技（上海）有限公司 OrigiMed